Focus today
[Tiandi Online: la verifica dei cambi di borsa è stata completata e il trading riprenderà il 21 novembre]
Tiandi Online announced that it has recently carried out verification work on issues related to stock transaction changes. In view of the completion of the verification work, upon request, the company’s shares will resume trading from the market opening on November 21st. Neither of the companies, the controlling shareholder and the effective controller have any major concerns about the company that should be disclosed but have not been disclosed.
[BESTORE: gli azionisti di Hillhouse prevedono di ridurre la partecipazione azionaria di non più del 5,56%]
BESTORE announced that Zhuhai Hillhouse Tianda Investment Center (Limited Partnership), HH LPPZ (HK) Holdings Limited and Ningbo Hillhouse Zhiyuan Enterprise Management Partnership (Limited Partnership) are shareholders acting jointly, holding 5.56% of the company shares. reduce the total holding of shares of the company to no more than 22.29 million shares, i.e. the total amount shall not exceed 5.56% of the total share capital of the company.
Investment and contract
[Alt: firmato un accordo quadro di cooperazione strategica con Ningde Times e Gecko Technology]
Alter announced that it has signed a strategic cooperation framework agreement with Ningde Times and Gecko Technology, and all parties agreed to cooperate in the fields of skateboard chassis, new energy vehicle business and new energy vehicle battery replacement. power.
【Brilliant Technology: Plan to set up a joint venture company to build green energy transportation and energy storage integration project】
Brilliant Technology announced that Brilliant Software, a wholly owned subsidiary of the company, signed an “Investment Cooperation Agreement” with State Power Investment Jinrun, Lankao City Investment and Telephone on November 18, and plans to jointly invest in the establishment of a joint venture capital project company Henan Electric Energy Easy Charge Technology Co., Ltd. The company is building a green energy transportation energy storage integration project; the above four parties are jointly responsible for the investment, construction, operation and management of the project in the Lankao area of Henan Province and timely development of new energy, distributed energy and comprehensive intelligent energy in the Lankao area of the Henan Province and other project resources. The registered capital of the joint venture project company is 50 million yuan, of which China Power Investment Jinrun plans to invest 27.5 million yuan, accounting for 55%; Brilliant Software plans to invest 9.5 million yuan, accounting for 19%; Telaidian plans to invest 1.5 million yuan, accounting for 3%.
Increase and decrease of holdings and repurchase
[Autocontrollo intelligente: azionisti, amministratori e supervisori, ecc. pianificano di ridurre le loro partecipazioni di non più del 4,72% delle azioni]
According to Intelligent Control’s announcement, several of the company’s shareholders and directors and supervisors plan to reduce their holdings in the company’s stock by no more than 15.7 million shares, or no more than 4.72 percent of the company’s total share capital. society.
[Collier: i supervisori della società intendono ridurre le loro partecipazioni di non più di 154.000 azioni della società]
Kelier announced that Jiang Yaogang, the company’s supervisor, plans to reduce his holdings in the company’s stock by no more than 154,000 shares, or 0.0489 percent of the company’s total share capital, through a centralized offering.
Winning contract and project
[Samsung Medical: ha pre-vinto l’offerta di circa 639 milioni di yuan per il National Grid Bidding and Procurement Project]
Samsung Medical announced that the company and its wholly owned subsidiary Ningbo Samsung Smart recently purchased the 61st lot of the State Grid in 2022 (the second tender and procurement of electricity meters for marketing projects) and the 62nd procurement batch in the State Grid in 2022 (in the marketing project, the second procurement project for the equipment replacement and charge agreement inventory tender) was recommended as the winning bid, and the total amount of winning bids it should be around 639 million yuan.
[Cambrian: firmato un contratto di vendita di attrezzature di circa 500 milioni di yuan]
The Cambrian announced that the company has signed an equipment procurement contract for the Nanjing Intelligent Computing Center Project (Phase II and Phase III) with Nanjing Science and Technology Innovation Investment Co., Ltd., with a contract value of 501 million yuan (tax included) . The company will deliver the products under the contract to Nanjing Science and Technology Innovation Investment Co., Ltd. within 90 days after signing the contract.
[Dashi Intelligent: ha vinto la gara per un progetto di ospedale intelligente da 237 milioni di yuan]
Dashi Intelligent announced that the company’s wholly owned subsidiary Dashi Jiuxin and joint contractor Guangdong Jieqi Construction Engineering Co., Ltd. recently received the “Notice of Winning Bid” and won the tender for the construction project general renovation (Phase II) of Bao ‘a district people’s hospital for medical technology and medical purification, medical pure water system project, the winning bid amount is about 237 million yuan, equal to 7, 49% of the company’s verified operating income in 2021.
[Azioni Tongda: pre-vinto l’offerta per il progetto di appalto State Grid 77,9678 milioni di yuan]
Tongda Co., Ltd. announced that the company is the winning candidate recommended by the state network for the 23rd batch of UHV project procurement in 2022 (Wuhan-Nanchang and other project line material tenders and procurement) package 8 and the material winning bid is the ground wire. According to the company’s calculations, the total value of the above winning materials is 77.9678 million yuan, which is about 3.3% of the company’s total operating income in 2021.
[Huijintong: pre-vinto l’appalto per il progetto di approvvigionamento di State Grid di circa 142 milioni di yuan]
Huijintong announced that the company is a bid bid for the 23rd lot of State Grid’s 2022 UHV project procurement projects (Wuhan-Nanchang and other engineering line material procurement and procurement projects).
change in the share price
[Hua Shengchang: Il ventilatore è in fase di test del prodotto e non ha ancora ottenuto la certificazione di registrazione medica]
Huashengchang issued a change announcement, the company’s recent operating conditions are normal, and there have been no major changes in the internal and external operating environment. At present, the company’s ventilator is in product testing and has not yet obtained medical registration certification.
Other
[*ST Stars: ha ricevuto una sanzione amministrativa e un preavviso di divieto di mercato a causa di una frode nel rapporto annuale]
*ST Xingxing announced that the company and related parties received the “Notice of Administrative Penalty and Market Entry Ban” issued by the China Securities Regulatory Commission on the 18th. After an investigation, it was found that the company was suspected of falsely increase operating income, total profit and understate the impairment of goodwill and other illegal facts. The company’s 2019 annual report and 2020 annual report contained false documents. Among them, in 2019, the fictitious sales companies such as Jiangxi Xingxing and Xingxing Touch, which are subsidiaries of Xingxing Technology, falsely increased their operating income by 1.384 billion yuan; turnover was 3.192 billion yuan. The China Securities Regulatory Commission intends to decide: (1) to give a warning to Xingxing Technology and impose a fine of 6 million yuan; (2) to give a warning to Liu Jianxun, Pan Qingshou and Liu Langwen and impose a fine of 4.5 million yuan respectively; Yang Shuming issued a warning and imposed a fine of 3 million yuan; (4) gave a warning to Zhang Shaohuai and Chen Meifen and imposed a fine of 800,000 yuan each; (5) gave Li Juan, Wang Jun and Dong Shenglian a warning and imposed a fine of 500,000 yuan each fine. In addition, Liu Jianxun, Pan Qingshou and Liu Langwen will be banned from the market for life; Yang Shuming will be banned from the market for 10 years.
[ST Xingyuan: ricevuto preavviso di sanzione amministrativa dall’ufficio di regolamentazione dei titoli di Shenzhen]
ST Xingyuan announced that the company recently received the “Notice of Administrative Fine” issued by the Shenzhen Securities Regulatory Bureau. After an investigation, the company was suspected of failing to disclose the main arbitrations and the main assets are been seized and frozen in accordance with the law; Warranty and other illegal facts. The Shenzhen Securities Regulatory Bureau plans to give Century Xingyuan a warning and a fine of 1 million yuan; a warning to Ding Peng and Zheng Lielie and a fine of 1 million yuan respectively; a warning to Zhao Jian and Luo Xiaochun and a fine of 600,000 yuan each A fine; Daniel Baozefang, Wang Xingli and Wang Qun received a warning and a fine of 500,000 yuan; Yongzheng Peak received a warning and a fine of 30,000 yuan. At present, the company’s operating conditions are normal.
[MaiweiBio:lanuovadomandadisperimentazioneclinicadifarmacidi9MW3011èstataapprovatadallaFDA]
Maiwei Bio announced that the company recently received the “Notice of Continuing Clinical Research” issued by the US Food and Drug Administration (“FDA”), and the New Drug Clinical Trial Application for 9MW3011 has been officially approved by the FDA . It is reported that 9MW3011 is an innovative target monoclonal antibody independently developed by the company’s Innovative Molecular Discovery Laboratory in San Diego, USA, and is a class 1 therapeutic biological product.
[Aosaikang: le compresse di Neratinib Maleate hanno ottenuto l’avviso di accettazione della domanda per la registrazione del farmaco e l’autorizzazione all’immissione in commercio]
Aosaikang announced that Jiangsu Aosaikang Pharmaceutical Co., Ltd., a wholly owned subsidiary of the company, recently received the “Notice of Acceptance” issued by the State Drug Administration for the marketing authorization application of Neratinib Maleate Tablets. Its subsidiary Neratinib Maleate Tablets was recently formally accepted for listing and application for registration, making it the second nationwide application for generics listing. The development of neratinib contributes to further enrich the company’s product layout in the breast cancer field and increase its competitiveness in the market.
【Pulley Pharma: Ganciclovir for Injection has been approved by the Finnish National Medicines Agency】
Puli Pharma announced that the company recently received the marketing authorization for ganciclovir for injection from the Finnish National Medicines Agency.
[Lexin Medical: la domanda di certificazione del prodotto per lo sfigmomanometro elettronico dell’azienda è stata accettata dalla FDA]
Lexin Medical announced that the company recently received the “Letter of Acknowledgment” (submission number: K223374) issued by the US FDA, and learned that the company’s electronic blood pressure monitor product certification application has been accepted by the FDA . This product plays a positive role in accelerating the establishment and improvement of enterprise health IoT and comprehensive remote health management solutions in the field of chronic disease management.
[Tecnologia Yongtai: produzione di prova di una consociata interamente controllata con una produzione annua di 150.000 tonnellate di progetto elettrolitico]
Yongtai Technology announced that recently, the wholly owned subsidiary of the company, Zhejiang Yongtai New Energy Materials Co., Ltd., completed the installation and commissioning of the equipment in the production workshop of the electrolyte project with an annual output of 150,000 tons. reviewed by experts on November 18, 2022. pass. The design met the test production conditions and officially entered the test production phase. The commissioning of the project is conducive to further integration of the company’s lithium battery materials industry chain.
[Lianshi Aviation: una consociata interamente controllata Chengdu Hangyu Aumento di capitale per presentare investitori]
Lianshi Aviation announced that, according to the company’s strategic development needs, it has decided to introduce Yang Xianjun, Zhang Yu and Yang Yang to increase the capital and stake of wholly owned subsidiary Chengdu Hangyu Superalloy Technology Co., Ltd. Si agrees that Yang Xianjun will invest 40 million yuan, Zhang Yu will contribute 20 million yuan, and Yang Yang will contribute 5 million yuan to subscribe for additional registered capital. After the capital increase, the company’s stake in Chengdu Aerospace decreased from 100% to 93.8967%. The company waives the priority right to subscribe the capital grant for the new capital increase of Chengdu Hangyu.
